Grant: CIHR Fellowship
University of Toronto
$210,000.00
Aligning neurodevelopmental trajectories between fetal brains and organoids to identify novel mechanisms and treatments for autism
FY 2024-25
Summary
Autism affects 1 in 100 children, profoundly altering early brain development with a lifelong impact on cognition and social skills. The fundamental challenge to developing treatments is a lack of understanding of how human brain cells develop early on, and how this process is disrupted in autism. Modeling autism in mice is challenging due to the diverse genetic factors linked to autism, in addition to major differences between human and mouse brain development that are yet to be fully understood. Lab-grown mini-brains called brain organoids derived from stem cells mimic aspects of early human brain development, offering an exciting model to study autism and test treatments. My work tackles the complex origins of autism using a data-driven approach that spans the depth and breadth of brain development across species and organoid model systems. I propose to analyze normal brain development, one cell at a time, using data from the human fetal brain and brain organoids. By mapping how normal brain cells develop, I will identify molecular programs that are likely to be impacted in autism. Extending my analysis to mice and non-human primates will provide the breadth needed to uncover human-specific features of brain development that are susceptible to disease. This approach will align the clocks of brain cell development across species, revealing specific vulnerable periods that can be targeted for treatment. Finally, I will measure the impact of perturbing autism genes on brain cell fate and assess treatments that counteract these effects. These dry-lab experiments will prioritize thousands of autism genes by their impact on brain development, serving as a valuable guide to the research community for experimental validation and paving the path to novel treatment strategies.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
513603
Name
Venkatesan Sridevi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Aligning neurodevelopmental trajectories between fetal brains and organoids to identify novel mechanisms and treatments for autism
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Autism; Bioinformatics; Brain Organoids; Functional Genomics; Meta-Analysis; Neurodevelopment; Single Cell Rnaseq
Abstract
Autism affects 1 in 100 children, profoundly altering early brain development with a lifelong impact on cognition and social skills. The fundamental challenge to developing treatments is a lack of understanding of how human brain cells develop early on, and how this process is disrupted in autism. Modeling autism in mice is challenging due to the diverse genetic factors linked to autism, in addition to major differences between human and mouse brain development that are yet to be fully understood. Lab-grown mini-brains called brain organoids derived from stem cells mimic aspects of early human brain development, offering an exciting model to study autism and test treatments. My work tackles the complex origins of autism using a data-driven approach that spans the depth and breadth of brain development across species and organoid model systems. I propose to analyze normal brain development, one cell at a time, using data from the human fetal brain and brain organoids. By mapping how normal brain cells develop, I will identify molecular programs that are likely to be impacted in autism. Extending my analysis to mice and non-human primates will provide the breadth needed to uncover human-specific features of brain development that are susceptible to disease. This approach will align the clocks of brain cell development across species, revealing specific vulnerable periods that can be targeted for treatment. Finally, I will measure the impact of perturbing autism genes on brain cell fate and assess treatments that counteract these effects. These dry-lab experiments will prioritize thousands of autism genes by their impact on brain development, serving as a valuable guide to the research community for experimental validation and paving the path to novel treatment strategies.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Venkatesan, Sridevi
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~